- ►diabetesjournals.org [PDF] MJ Tikkanen, M Laakso, M Ilmonen, E Helve, E … - Diabetes Care, 1998 - Am Diabetes Assoc NIDDM is elevated plasma triglyceride lev- els associated with a low HDL
cholestero l concentration (3). In contrast, although high LDL cholesterol is
not uncommon in NIDDM patients, its occurrence appears to re flect the ... Cited by 49 - Related articles - BL Direct - All 8 versions
T Jeck, WF Riesen, U Keller - Diabetic Medicine, 1997 - interscience.wiley.com Fibrates and HMG CoA reductase inhibitors are commonly used in the treatment of
diabetic dyslipidaemia. However, these two groups of drugs have not been
compared in diabetic patients in a randomized controlled trial. Therefore, ... Cited by 24 - Related articles - BL Direct - All 3 versions
MJ Tikkanen, M Laakso, M Ilmonen, E Helve, E … - Diabetes Care, 1998 - Am Diabetes Assoc NIDDM is elevated plasma triglyceride lev- els associated with a low HDL
cholestero l concentration (3). In contrast, although high LDL cholesterol is
not uncommon in NIDDM patients, its occurrence appears to re flect the ... Related articles
RH Knopp, J Frohlich, K Dawson, LA … - The American journal of medicine, 1994 - Elsevier The purpose of this study was to investigate the triglyceride-lowering effect of
fluvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitor, in the combined hyperlipidemia of non-insulin-dependent diabetes ... Cited by 37 - Related articles - BL Direct - All 6 versions
R Goldberg, P La Belle, R Zupkis, P Ronca - The American journal of cardiology, 1990 - ncbi.nlm.nih.gov Patients with non-insulin dependent diabetes mellitus have an increased
incidence of coronary artery disease which may, in part, be associated with
abnormalities in plasma lipids. In a double-blind, parallel, randomized ... Cited by 34 - Related articles - All 2 versions
S Lahdenperä, M Tilly-Kiesi, H Vuorinen- … - Diabetes Care, 1993 - Am Diabetes Assoc OBJECTIVE--To study the effects of gemfibrozil treatment on LDL particle size,
density distribution, and composition in NIDDM patients. RESEARCH DESIGN AND
METHODS--We performed LDL analyses on 16 NIDDM patients with stable ... Cited by 73 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org TC Ooi, T Heinonen, P Alaupovic, J Davignon, … - Arteriosclerosis, Thrombosis, and Vascular Biology, 1997 - Am Heart Assoc From the Ottawa Civic Hospital, Ottawa, Ontario, Canada (TCO, AS); Parke-Davis
Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, Mich (TH,
LS, DMB); Lipid and Lipoprotein Laboratory, Oklahoma Medical Research ... Cited by 52 - Related articles - BL Direct - All 5 versions
[CITATION] Pradiktoren eines letalen Verlaufs von Myokardinfarkten bei Typ-2-Diabetikern Predictors of …
IJ Meier, A Klamann, M Heimesaat, P Sarfert … - Diabetes und Stoffwechsel, 2000 - KIRCHHEIM+ CO GMBH Cited by 4 - Related articles - BL Direct
[CITATION] QT-Zeit-Verlängerung bei Typ-I-und Typ-II-Diabetikern: eine enge Korrelation zur …
P Kempler, A Varadi, E Kadar, Z Hermanyi, G … - Diabetes und Stoffwechsel, 1992 Cited by 5 - Related articles
M Farrer, PH Winocour, K Evans, HAW Neil, MF … - Diabetes research and clinical practice, 1994 - cat.inist.fr Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum
lipids, lipoproteins and haemostatic measures. M FARRER, PH ... Cited by 38 - Related articles - All 3 versions
